Home/ Stocks/ QUCY

Mainz Biomed N.V. Ordinary Shares

QUCY XNAS

$0.50 +0.00 (+0.46%) ▲ 15-min delayed

Open

$0.46

High

$0.50

Low

$0.44

Volume

199.6K

Market Cap

$6.00M

About Mainz Biomed N.V. Ordinary Shares

Mainz Biomed NV develops market-ready molecular genetic diagnostic solutions for life-threatening conditions. The company's flagship product is ColoAlert, is an accurate, non-invasive and easy-to-use, early-detection diagnostic test for colorectal cancer based on real-time Polymerase Chain Reaction-based (PCR) multiplex detection of molecular-genetic biomarkers in stool samples. The company operates in one operating segment, genetic diagnostic testing.

Employees: 26 Website →

Related Market News

No specific coverage for QUCY yet. Check out our latest market news or earnings calendar.

Get QUCY Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Mainz Biomed N.V. Ordinary Shares.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.